Paralos Bioscience Inc.

Biotech Los Angeles, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Los Angeles, CA
Street
570 Westwood Plaza Lab Room 6350
Zip
90095

Offering

Total offering
$1M
Amount sold
$329k
First sale
Jul 28, 2025
Min investment
$5k
Securities
Equity, Debt
Federal exemption
Rule 506(b)
Investors so far
3

How this filing compares

Ranked #36 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.3× the median.

Other California filings this week: Blue Opportunity Fund, LP, CHECKPOINT CAPITAL (OFFSHORE) FUND LP, CHECKPOINT CAPITAL (ONSHORE) FUND LP, CompleteFarmer Technologies, Inc., ExchangeRight Income Fund Operating Partnership, LP

Leadership

Irene Chen — Executive Officer (also: Director)

Yanxi Yang — Executive Officer

Filing details

Paralos Bioscience Inc. filed a Form D with the SEC on April 17, 2026.

Other newest Biotech companies

Other newest companies in California